カテゴリ： MarketLine, アメリカ, 企業調査

The Chemours Company LLC：企業の戦略・SWOT・財務情報

◆英語タイトル：The Chemours Company LLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3720
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：41
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

The Chemours Company LLC – Strategy, SWOT and Corporate Finance Report
Summary

The Chemours Company LLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Chemours Company, LLC (Chemours) is a provider of performance chemicals. Its major products include titanium dioxide (TiO2), industrial fluoropolymer resins, sodium cyanide, refrigerants, and performance chemicals and intermediates. The company delivers customized solutions with a wide range of industrial and specialty chemicals products, and application expertise. It sells products under brands such as Ti-Pure, Opteon, Krytox, Teflon, Viton, Freon, and Nafion. The company serves plastics and coatings, mining, oil refining, refrigeration and air conditioning, electronics and general industries across North America, Asia Pacific, Europe, Middle East, Africa, and Latin America. Chemours is headquartered in Wilmington, Delaware, the US.

Scope

- Detailed information on The Chemours Company LLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Chemours Company LLC in the form of a SWOT analysis
- An in-depth view of the business model of The Chemours Company LLC including a breakdown and examination of key business segments
- Intelligence on The Chemours Company LLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Chemours Company LLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Chemours Company LLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Chemours Company LLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Chemours Company LLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
The Chemours Company LLC: Company Overview 9
The Chemours Company LLC: Overview and Key Facts 9
The Chemours Company LLC: Overview 9
The Chemours Company LLC: Key Facts 9
The Chemours Company LLC: Key Employees 11
The Chemours Company LLC: Key Employee Biographies 12
The Chemours Company LLC: Major Products and Services 14
The Chemours Company LLC: Company History 15
The Chemours Company LLC: Management Statement 16
The Chemours Company LLC: Locations and Subsidiaries 18
The Chemours Company LLC: Key Competitors 20
The Chemours Company LLC: Company Analysis 21
The Chemours Company LLC: Business Description 21
The Chemours Company LLC: SWOT Analysis 22
The Chemours Company LLC: SWOT Overview 22
The Chemours Company LLC: Strengths 22
The Chemours Company LLC: Weaknesses 23
The Chemours Company LLC: Opportunities 23
The Chemours Company LLC: Threats 24
The Chemours Company LLC: Corporate Financial Deals Activity 25
The Chemours Company LLC: Financial Deals Overview 25
The Chemours Company LLC: Top Deals 2014 – 2018YTD* 27
The Chemours Company LLC: Advisors 28
The Chemours Company LLC: Top Legal Advisors 28
The Chemours Company LLC: Top Financial Advisors 28
The Chemours Company LLC: Capital Raising 30
The Chemours Company LLC: Divestments 31
The Chemours Company LLC: Recent Developments 32
The Chemours Company LLC: News and Events Summary 32
The Chemours Company LLC: Business Expansion 34
The Chemours Company LLC: Contracts 34
The Chemours Company LLC: Corporate Governance 35
The Chemours Company LLC: Financial Deals 36
The Chemours Company LLC: Financial Performance 36
The Chemours Company LLC: Strategy and Operations 37
Appendix 39
Contact Us 39
Methodology 39
About MarketLine 40

List of Tables
Table 1: The Chemours Company LLC: Key Facts
Table 2: The Chemours Company LLC: Key Employees
Table 3: The Chemours Company LLC: Locations and Subsidiaries
Table 4: The Chemours Company LLC: Key Competitors
Table 5: The Chemours Company LLC: Deal Activity by Deal Type - Volume (TTM*)
Table 6: The Chemours Company LLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: The Chemours Company LLC: Top Deals 2014 - 2018YTD*
Table 8: The Chemours Company LLC: Legal Advisor Ranking by Value (US$m)
Table 9: The Chemours Company LLC: Financial Advisor Ranking by Value (US$m)
Table 10: The Chemours Company LLC: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 11: The Chemours Company LLC: Capital Raising by Deal Type (2014 - YTD*2018)
Table 12: The Chemours Company LLC: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: The Chemours Company LLC: Divestments by Geography (2014 - YTD*2018)
Table 14: The Chemours Company LLC: News and Events Summary
Table 15: The Chemours Company LLC: Business Expansion
Table 16: The Chemours Company LLC: Contracts
Table 17: The Chemours Company LLC: Corporate Governance
Table 18: The Chemours Company LLC: Financial Deals
Table 19: The Chemours Company LLC: Financial Performance
Table 20: The Chemours Company LLC: Strategy and Operations

List of Figures
Figure 1: The Chemours Company LLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: The Chemours Company LLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: The Chemours Company LLC: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: The Chemours Company LLC: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 5: The Chemours Company LLC: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: The Chemours Company LLC: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[The Chemours Company LLC：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Equifax Inc.：企業の戦略・SWOT・財務分析
    Equifax Inc. - Strategy, SWOT and Corporate Finance Report Summary Equifax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Carlsberg Brewery Malaysia Berhad：戦略・SWOT・企業財務分析
    Carlsberg Brewery Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Carlsberg Brewery Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Sprint Corporation：企業の戦略・SWOT・財務情報
    Sprint Corporation - Strategy, SWOT and Corporate Finance Report Summary Sprint Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • DaVita Inc (DVA)：企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Azul SA (AZUL)：企業の財務・戦略的SWOT分析
    Azul SA (AZUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Boston Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Boston Pharmaceuticals Inc (Boston Pharma) is a drug development company that develops new drugs for unmet needs. The company acquires and advances various drug candidates from investigational new drug application (IND) through Phase 2 including BOS161721, BOS172767, BOS173717, BOS172722, BO …
  • Bayerische Patentallianz GmbH-製薬・医療分野：企業M&A・提携分析
    Summary Bayerische Patentallianz GmbH (Bayerische Patentallianz) is a central patent and marketing agency that evaluates and markets the inventions, protecting, marketing and achieving financial benefits. The agency provides support and consulting services to small and medium businesses and free inv …
  • SLM Corp：企業の戦略・SWOT・財務情報
    SLM Corp - Strategy, SWOT and Corporate Finance Report Summary SLM Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Bone Biologics Corp (BBLG)：企業の製品パイプライン分析
    Summary Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. It develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers N …
  • AFFiRiS AG-製薬・医療分野：企業M&A・提携分析
    Summary Affiris AG (AFFiRiS) is a drug development company that develops and manufactures novel synthetic vaccines against chronic diseases. The company develops customized peptide vaccines based on its proprietary affitome technology for the prevention of Alzheimer's disease, Parkinson's disease, a …
  • CenterPoint Energy Inc (CNP)：石油・ガス：M&Aディール及び事業提携情報
    Summary CenterPoint Energy Inc (CenterPoint) is an energy utility company that carries out electric transmission and distribution, and natural gas distribution. It is also involved in natural gas sales and service, pipeline services and other field services. The company sells regulated intrastate na …
  • R. R. Donnelley & Sons Co (RRD)：企業の財務・戦略的SWOT分析
    R. R. Donnelley & Sons Co (RRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tishman Realty & Construction Co., Inc.：企業の戦略・SWOT・財務情報
    Tishman Realty & Construction Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Tishman Realty & Construction Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Brokk AB：企業の戦略的SWOT分析
    Brokk AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Wexford Health Sources Inc：企業の戦略的SWOT分析
    Wexford Health Sources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Viscofan, S.A.：企業の戦略・SWOT・財務情報
    Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report Summary Viscofan, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Maruho Co Ltd：企業の戦略的SWOT分析
    Maruho Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Prognomix Inc：企業の製品パイプライン分析
    Summary Prognomix Inc (Prognomix) is a personalized medicine company that develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. The company’s products include PGX IR01, PGx GR01, PGx CD01, PGx IR02 …
  • Korn Ferry (KFY)：企業の財務・戦略的SWOT分析
    Korn Ferry (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ryosan Company, Ltd：企業の戦略・SWOT・財務分析
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆